Nonadherence to antiseizure medications: what have we learned and what can be done next?

IF 1.8 4区医学 Q3 HEALTH CARE SCIENCES & SERVICES

Expert Review of Pharmacoeconomics & Outcomes Research Pub Date : 2024-04-27 DOI:10.1080/14737167.2024.2349191

Sinaa Al-Aqeel

引用次数: 0

Abstract

Nonadherence to antiseizure medications (ASMs) is associated with increased mortality, morbidity, health care utilization and costs.This article reviewed 18 randomized controlled trials published b...

查看原文本刊更多论文

不坚持服用抗癫痫药物：我们学到了什么，下一步该怎么做？

不坚持服用抗癫痫药物（ASMs）与死亡率、发病率、医疗保健使用率和成本增加有关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Review of Pharmacoeconomics & Outcomes Research HEALTH CARE SCIENCES & SERVICES-PHARMACOLOGY & PHARMACY

CiteScore

4.00

自引率

4.30%

发文量

审稿时长

6-12 weeks

期刊介绍： Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points.